Featuring Alex Kozinski, Judge, U.S. Court of Appeals for the Ninth Circuit; and J. Harvie Wilkinson III, Judge, U.S. Court of Appeals for the Fourth Circuit; moderated by Tim Lynch, Director, Project on Criminal Justice, Cato Institute.
So many Americans are concerned with how “Washington isn’t listening to them,” and candidates like Bernie Sanders, Donald Trump, and Ben Carson are stoking that outrage. But maybe Washington isn’t listening because it is so big that only mobilized special interests have the resources and incentives to pay attention. Maybe big government will never really pay attention to the people. If this is so, then maybe people should stop trying to control each other so much.
American leaders have cooperated with regimes around the world that are, to varying degrees, repressive or corrupt. Such cooperation is said to serve the national interest. But these partnerships also contravene the nation’s commitments to democratic governance, civil liberties, and free markets. In Perilous Partners, authors Ted Galen Carpenter and Malou Innocent provide a strategy for resolving the ethical dilemmas between interests and values faced by Washington.
The Cato Institute has released its 2014 Annual Report, which documents a dynamic year of growth and productivity. “Libertarianism is the philosophy of freedom,” Cato’s David Boaz writes in his book, The Libertarian Mind. “It is the indispensable framework for the future.” And as the new report demonstrates, the Cato Institute, thanks largely to the generosity of our Sponsors, is leading the charge to apply this framework across the policy spectrum.
Resolved: Congress Should Remove the Ban on Drug Reimportation
In the affirmative, Roger Pilon,
Vice President for Legal Affairs, Cato Institute; in the negative, John E. Calfee,
Resident Scholar, American Enterprise Institute.
In this election year, the drug reimportation debate is heating up. Last year the House easily passed a bill that would allow Americans to buy prescription drugs abroad, where they sell at far below American prices, but the bill stalled in the Senate. This year pressure is building from governors, mayors, and ordinary citizens, many of whom are simply ignoring the current ban on importing drugs. Proponents of the bill say that free trade is likely to reduce the high prices Americans now pay for prescription drugs. Opponents raise safety concerns and add that the bill would amount to importing foreign price controls. Please join us for a timely debate on an issue that touches millions of Americans.